Trial Profile
Retrospective observational study to determine fetal outcomes in women exposed to topiramate during pregnancy.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Dec 2011
Price :
$35
*
At a glance
- Drugs Topiramate (Primary)
- Indications Obesity; Pregnancy
- Focus Adverse reactions; Registrational
- Acronyms FORTRESS
- 21 Dec 2011 Status changed from recruiting to completed, according to a VIVUS media release.
- 15 Sep 2011 Planned number of patients changed to 2500, according to a VIVUS media release.
- 01 Aug 2011 Status changed from planning to recruiting.